- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lichen Sclerosus
Total 4633 results
-
SanofiRecruitingMultiple SclerosisKorea, Republic of, United States, China, Canada, Australia, Puerto Rico, United Kingdom, Turkey, Japan
-
University of CalgaryRecruiting
-
Danish Research Centre for Magnetic ResonanceScleroseforeningen; Danish Multiple Sclerosis CenterRecruitingPrimary Progressive Multiple SclerosisDenmark
-
Novartis PharmaceuticalsCompletedMayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoSecondary Progressive Multiple SclerosisAustralia
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more
-
University of NottinghamNottingham University Hospitals NHS TrustCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
University College, LondonUniversity of Leeds; University of Sheffield; Medical Research Council; Queen Mary... and other collaboratorsCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Isfahan University of Medical SciencesCompletedSecondary Progressive Multiple SclerosisIran, Islamic Republic of
-
BiogenTerminatedSecondary Progressive Multiple SclerosisUnited States, Finland, Italy, Spain, Canada, France, Israel, Sweden, Netherlands, Belgium, Poland, United Kingdom, Czechia, Denmark, Russian Federation, Germany, Ireland
-
Merck KGaA, Darmstadt, GermanyMerck Quimica Argentina S.A.I.CCompletedMultiple Sclerosis, Relapsing RemittingArgentina
-
Eli Lilly and CompanyBioMS Technology Corp.TerminatedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Latvia, Spain, Sweden, United Kingdom, Germany, Netherlands
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedSecondary Progressive Multiple SclerosisGermany
-
BiogenCompletedDoes Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)Relapsing Remitting Multiple SclerosisBelgium, Luxembourg, United Kingdom
-
Amanda IrishCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
University of IowaDJO Incorporated; Direct MS Canada; Pinnaclife Inc.; TZ Press, LLCCompletedMultiple SclerosisUnited States
-
National Institute of Neurological Disorders and...Terminated
-
Amphia HospitalSanofi; TEVA PharmachemieUnknown
-
Horizon Therapeutics USA, Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States
-
Talaris Therapeutics Inc.WithdrawnDiffuse Cutaneous Systemic SclerosisUnited States
-
Lawson Health Research InstituteSeagen Inc.CompletedDiffuse Cutaneous Systemic SclerosisCanada
-
Novartis PharmaceuticalsCompletedSystemic Sclerosis, SclerodermaUnited States, Germany, Italy, Switzerland, United Kingdom
-
Corbus Pharmaceuticals Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States
-
Corbus Pharmaceuticals Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States, Switzerland, Korea, Republic of, Australia, Netherlands, Israel, United Kingdom, Germany, Japan, Spain, Poland, Canada
-
Inventiva PharmaCompletedScleroderma, Diffuse | Diffuse Cutaneous Systemic SclerosisUnited Kingdom, France, Spain, Switzerland, Italy, Slovenia, Netherlands, Germany, Bulgaria, Poland
-
Stem Cell Medicine Ltd.WithdrawnSecondary Progressive Multiple Sclerosis (SPMS)Israel
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple Sclerosis (SPMS)Japan
-
Novartis PharmaceuticalsTerminatedDepression | Relapsing-remitting Multiple SclerosisGermany
-
Fundación Pública Andaluza para la gestión de la...RecruitingNervous System Diseases | Autoimmune Diseases of the Nervous System | Autoimmune Diseases | Sclerosis, MultipleSpain
-
University of JaénCompletedSclerosis, MultipleSpain
-
BiogenApproved for marketingSuperoxide Dismutase 1-Amyotropic Lateral SclerosisUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Seagen...CompletedDiffuse Cutaneous Systemic Sclerosis | Scleroderma | dcSScUnited States
-
Comenius UniversityCompletedSclerosis, MultipleSlovakia
-
University Hospital, Strasbourg, FranceRecruitingJuvenile Systemic SclerosisFrance
-
Rikshospitalet University HospitalTerminated
-
Chulalongkorn UniversityRatchadapiseksompotch FundUnknownLichen AmyloidosisThailand
-
Kyowa Kirin Co., Ltd.Active, not recruitingModerate to Severe Systemic SclerosisJapan
-
University Hospital, GhentCompletedEarly and Severe Systemic SclerosisBelgium
-
University of MichiganPfizerCompletedSystemic Sclerosis | SclerodermaUnited States
-
Assistance Publique - Hôpitaux de ParisRoche Pharma AG; Institut du Cerveau et de la Moelle épinièreRecruitingMultiple Sclerosis | Relapse | Primary Progressive Multiple SclerosisFrance
-
Rennes University HospitalRecruiting
-
University of MinnesotaActive, not recruiting
-
Novartis PharmaceuticalsAvailable
-
University of VirginiaNational Multiple Sclerosis SocietyUnknownClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisUnited States
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
BiogenTerminatedMultiple Sclerosis, Secondary ProgressiveUnited States, Poland, Belgium, Slovakia, Czech Republic, Netherlands
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-remittingArgentina
-
BiogenWithdrawn
-
University College London HospitalsCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Institut de Recherche sur la Moelle épinière et...Groupe Hospitalier Pitie-Salpetriere; Institut de Myologie, France; Association... and other collaboratorsRecruitingALS - Amyotrophic Lateral SclerosisFrance